Lataa...
Combating devastating COVID-19 by drug repurposing
Despite advances in drug discovery, viral infections remain a major challenge for scientists across the globe. The recent pandemic of COVID-19 (coronavirus disease 2019), caused by a viral infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has created a disastrous situation...
Tallennettuna:
| Julkaisussa: | Int J Antimicrob Agents |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7162749/ https://ncbi.nlm.nih.gov/pubmed/32305589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.105984 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|